Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
In 1966, Welborn et al. (1) studied 19 nondiabetic patients with essential hypertension and demonstrated that these individuals had significantly higher plasma insulin concentrations compared with a normotensive control group. Although these observations suggested that the prevalence of resistance to insulin-mediated glucose disposal would be increased in patients with essential hypertension, it wasn’t until approximately 20 yr later that several research groups demonstrated that this was the case (2–7). Although the relationship between insulin resistance, hyperinsulinemia, and essential hypertension has been extensively studied in the past 15 yr, questions continue to be raised as to the nature of the link between these variables. Indeed, there is not even consensus as to whether or not there is a physiological relationship between insulin resistance/compensatory hyperinsulinemia and blood pressure regulation. Another issue, and perhaps of greater clinical relevance, is whether the insulin resistance/compensatory hyperinsulinemia that is frequently present in patients with essential hypertension plays any role in the increased prevalence of cardiovascular disease (CVD) that is the major cause of morbidity and mortality in this clinical syndrome. The goals of this review are to address both of these issues. To begin with, the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension will be summarized…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, hypertension is an insulin-resistant state and PA is frequently associated with hypertension [25,26].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [26]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · cited 1×
“Essentially identical findings were observed when the relationship between plasma asymmetric dimethylarginine (ADMA) concentration and insulin-mediated glucose disposal was evaluated (36).”
BackgroundSelf-citationInsulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530 · cited 1×
“On the basis of these and other findings (7), approximately 50% of patients with essential hypertension can be considered to be insulin resistant and hyperinsulinemic.”
BackgroundRacial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
SHEN, D.-C., SHIEH, S.-M., FUH, M. M.-T., WU, D.-A., CHEN, Y.-D. I., & REAVEN, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420
Self-citationYeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414 · cited 1×
“Resistance to insulin-mediated glucose disposal and compensatory hyperinsulinemia are continuous variables (25), not dichotomous ones, and there is no simple way to classify a person as being insulin resistant or insulin sensitive.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Reaven, 1993, Treatment of hypertension; focus on prevention of coronary heart disease., J Clin Endocrinol Metab, 76, 537
Cited by
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Insulin and insulin resistance.
Wilcox, G. (2005) · PubMed Central · Cited by 2,082
HYPERTENSION: Trends in Prevalence, Incidence, and Control
Hajjar, I., Kotchen, J. M., & Kotchen, T. A. (2006) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.27.021405.102132 · Cited by 531
Reaven, G. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.002 · Cited by 507
“It cannot be discussed in detail in the context of this article, but it recently was reviewed [30].”
BackgroundSelf-citationRochette, L., Lorin, J., Zeller, M., Guilland, J.-C., Lorgis, L., Cottin, Y., & Vergely, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.004 · Cited by 456
“Insulin resistance, as well as hypertension and hyperglycemia, is a central component of metabolic syndrome, and has been associated with an increase in cardiovascular risk (Reaven, 2003).”
BackgroundCheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312
“80 Hypertension (130/85 mmHg) 79 (39) 45 (19) 0.”
BackgroundSelf-citationEndothelial inflammation in insulin resistance
SJOHOLM, A., & NYSTROM, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70804-7 · Cited by 278
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
The Obesity Pandemic: Where Have We Been and Where Are We Going?
Roth, J., Qiang, X., Marbán, S. L., Redelt, H., & Lowell, B. C. (2004) · Obesity Research · doi:10.1038/oby.2004.273 · Cited by 262
“The second new development is the shift from four (or more) components of the metabolic syndrome to a single focus on insulin resistance (119,120).”
BackgroundInfluentialMetabolic syndrome and non-alcoholic fatty liver disease
Almeda-Valdés, P., Cuevas-Ramos, D., & Alberto Aguilar-Salinas, C. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31822-8 · Cited by 229
McLaughlin, T. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.642 · Cited by 201
“Systolic BP, mm Hg 123 (18) 130 (17) 139 (20)§|| .”
Self-citationClinical Studies on Chromium Picolinate Supplementation in Diabetes Mellitus—A Review
Broadhurst, C. L., & Domenico, P. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.677 · Cited by 178
Khan, A. M., Cheng, S., Magnusson, M., Larson, M. G., Newton-Cheh, C., McCabe, E. L., Coviello, A. D., Florez, J. C., Fox, C. S., Levy, D., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1182 · Cited by 176
“These findings highlight the influence of metabolic factors, particularly insulin resistance, on the cardiac NP system and suggest a potential mechanism for susceptibility to hypertension-related disorders in individuals with insulin resistance (32–34).”
Inflammation, Hypertension, and the Metabolic Syndrome
Grundy, S. M. (2003) · JAMA · doi:10.1001/jama.290.22.3000 · Cited by 170
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Bremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Wang, W., Saville, B. R., & Havel, P. J. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00298.x · Cited by 148
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
Hamerman, D. (2005) · QJM · doi:10.1093/qjmed/hci077 · Cited by 156
Reaven, G. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.12.001 · Cited by 167
Self-citationReaven, G. M. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00439.x · Cited by 138
Self-citationKatakam, P. V. G., Jordan, J. E., Snipes, J. A., Tulbert, C. D., Miller, A. W., & Busija, D. W. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2006 · Cited by 133
“Without necessary dietary and lifestyle modifications, the IR syndrome progresses to type II diabetes mellitus (40).”
BackgroundInfluence of Cardiometabolic Risk Factors on Platelet Function
Barale, C., & Russo, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020623 · Cited by 133
Characterization of the regulation of renal Na+/H+exchanger NHE3 by insulin
Fuster, D. G., Bobulescu, I. A., Zhang, J., Wade, J., & Moe, O. W. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00240.2006 · Cited by 118
“A pathogenic role has been proposed for chronic insulin-stimulated Na absorption causing volume expansion and hypertension in type II diabetes mellitus and the metabolic syndrome (50), but this conjecture has been countered by others (24).”
BackgroundFallo, F., Pozza, A. D., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Piazza, L. D., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.007 · Cited by 122
Ho, H. V. T., Jovanovski, E., Zurbau, A., Mejía, S. B., Sievenpiper, J. L., Au‐Yeung, F., Jenkins, A. L., Duvnjak, L. S., Leiter, L. A., & Vuksan, V. V. V. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.142158 · Cited by 121
“Research indicates that insulin has profound effects on lipid metabolism, primarily by stimulating the rate-limiting enzyme in cholesterol synthesis (42, 43).”
BackgroundYILMAZ, M. I., SONMEZ, A., CAGLAR, K., CELIK, T., YENICESU, M., EYILETEN, T., ACIKEL, C., OGUZ, Y., YAVUZ, I., & VURAL, A. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00764.x · Cited by 111
“Although hypertension is a component of metabolic syndrome, it has been shown that insulin resistant is not present in every hypertensive patient.(30) Previously we reported that young active men with new onset uncomplicated hypertension, have no significant change in plasma adiponectin levels and there were no correl…”
BackgroundMaki, K. C., Rains, T. M., Kaden, V. N., Raneri, K. R., & Davidson, M. H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.724 · Cited by 123
“Insulin has a stimulatory effect on VLDL synthesis (32).”
BackgroundSinaiko, A. R., Steinberger, J., Moran, A., Hong, C.-P., Prineas, R. J., & Jacobs, D. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000237863.24000.50 · Cited by 119
Krug, A. W., & Ehrhart‐Bornstein, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109439 · Cited by 106
Adiponectin and Insulin Sensitivity in Primary Aldosteronism
FALLO, F., DELLAMEA, P., SONINO, N., BERTELLO, C., ERMANI, M., VETTOR, R., VEGLIO, F., & MULATERO, P. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.012 · Cited by 101
Pang, X., Zhao, J., Zhang, W., Zhuang, X., Wang, J., Xu, R., Xu, Z., & Qu, W. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.02.002 · Cited by 101
Insulin-Sensitizing Antihyperglycemic Drugs and Mortality After Acute Myocardial Infarction
Inzucchi, S. E., Masoudi, F. A., Wang, Y., Kosiborod, M., Foody, J. M., Setaro, J. F., Havranek, E. P., & Krumholz, H. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1680 · Cited by 101
“Insulin resistance, the primary metabolic defect in type 2 diabetes, has been associated with cardiovascular disease (22), although there is yet no compelling evidence from prospective studies to suggest that improving insulin sensitivity decreases cardiovascular event rates.”
BackgroundRomeo, S., Vidal‐Puig, A., Husain, M., Ahima, R. S., Arca, M., Bhatt, D. L., Diehl, A. M., Fontana, L., Foo, R., Frühbeck, G., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf314 · Cited by 109
“45 Insulin resistance, even in the absence of dysglycaemia or pre-diabetes, is predictive of several cardiometabolic traits, such as endothelial dysfunction, hypertension, 46 chronic kidney disease (CKD), 47 steatotic liver disease, 48 left ventricular diastolic dysfunction, 49 and ASCVD.”
A Practical “ABCDE” Approach to the Metabolic Syndrome
Blaha, M. J., Bansal, S., Rouf, R., Golden, S. H., Blumenthal, R. S., & DeFilippis, A. P. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.8.932 · Cited by 111
Hypertension, insulin resistance, and the metabolic syndrome
Natali, A., & Ferrannini, E. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.007 · Cited by 105
Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome
López-Jaramillo, P., Sánchez, R. A., Diaz, M., Cobos, L., Bryce, A., Parra Carrillo, J. Z., Lizcano, F., Lanas, F., Sinay, I., Sierra, I. D., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835c5444 · Cited by 90
“It is commonly accepted that all components of metabolic syndrome are associated with insulin resistance [26,62,63].”
BackgroundFan, J., Zhang, X., Zhang, J., Zhao, T., Burley, S. K., & Zheng, X. F. S. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116811 · Cited by 94
“55 In this scenario, slightly better glucose tolerance in the glucose tolerance test (GTT)/insulin tolerance test (ITT) assays might be maintained by elevated insulin secretion, even if subtle insulin resistance exists.”
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Ceolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A., & Avogaro, A. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1344 · Cited by 87
“Previous epidemiological studies have indicated a close relation between plasma insulin levels and the incidence of cardiovascular disease, supporting the hypothesis that hyperinsulinemia, as a reflection of insulin resistance, may be an atherogenic factor (20,21).”
BackgroundMenopause, the metabolic syndrome, and mind-body therapies
Innes, K. E., Selfe, T. K., & Taylor, A. G. (2008) · Menopause · doi:10.1097/01.gme.0b013e318166904e · Cited by 85
Use of Ferulic Acid in the Management of Diabetes Mellitus and Its Complications
Li, X., Wu, J., Xu, F., Chu, C., Li, X., Shi, X., Zheng, W. L., Wang, Z., Jia, Y., & Xiao, W. (2022) · Molecules · doi:10.3390/molecules27186010 · Cited by 97
Moxonidine: A Review of its Use in Essential Hypertension
Fenton, C., Keating, G. M., & Lyseng-Williamson, K. A. (2006) · Drugs · doi:10.2165/00003495-200666040-00006 · Cited by 84
Vasdev, S., Gill, V. D., & Singal, P. K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0039-0 · Cited by 87
“Furthermore, they are both associated with insulin resistance [11–15], and we suggest that this common link may be at the etiological root of”
BackgroundModulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants.
Vasdev, S., Gill, V. D., & Singal, P. K. (2006) · PubMed · Cited by 90
Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Abdul‐Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Suwaidi, J. M. S. A. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666171010115119 · Cited by 82
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?
Moreira, M. C. D. S., Pinto, I. S. D. J., Mourão, A. A., Fajemiroye, J. O., Colombari, E., Reis, Â. A. D. S., Freiria-Oliveira, A. H., Neto, M. L. F., & Pedrino, G. R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00234 · Cited by 87
“Since there are direct relationships between sedentary lifestyle and cardiovascular risk factors, the benefits of physical exercises on the prognosis of the MS are clear (Lakka et al., 2003; Rennie et al., 2003).”
BackgroundGuidelines on the management of arterial hypertension and related comorbidities in Latin America
(2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001418 · Cited by 73
Vasdev, S., Gill, V. D., & Singal, P. K. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.263 · Cited by 83
“Insulin resistance has also been documented in humans with atherosclerosis (DeFronzo and Ferrannini 1991; Howard et al 1996; Shinozaki et al 1996; Reaven 2003).”
Maki, K. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.02.001 · Cited by 76
Kudo, M., Sugawara, A., Uruno, A., Takeuchi, K., & Ito, S. (2004) · Endocrinology · doi:10.1210/en.2004-0180 · Cited by 69
Sasaki, N., Ozono, R., Higashi, Y., Maeda, R., & Kihara, Y. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015546 · Cited by 70
“9 Hyperglycemia causes hyperosmolarity, leading to fluid shift from the intracellular compartment to the extracellular compartment, which results in plasma volume expansion.”
Suarez, E. C. (2006) · Health Psychology · doi:10.1037/0278-6133.25.4.484 · Cited by 63
Fullmer, M., Abrams, S. H., Hrovat, K. B., Mooney, L., Scheimann, A. O., Hillman, J. B., & Suskind, D. L. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318231db79 · Cited by 72
Abdulla, M. H., Sattar, M. Z. A., & Johns, E. J. (2011) · International Journal of Nephrology · doi:10.4061/2011/934659 · Cited by 63
“Insulin stimulates glucose uptake, increases glycogen synthesis, and decreases gluconeogenesis and if the hormone is unable to elicit these actions, insulin resistance is said to exist and results in increased plasma insulin levels [51–53].”
Bremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Ampah, S. B., Saville, B. R., & Havel, P. J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.178061 · Cited by 56
Pitsavos, C., Panagiotakos, D. B., Tzima, N., Lentzas, Y., Chrysohoou, C., Das, U. N., & Stefanadis, C. (2007) · Angiology · doi:10.1177/0003319707300014 · Cited by 51
El‐Bassossy, H. M., Abo‐Warda, S. M., & Fahmy, A. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500724 · Cited by 50
The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?
Reaven, G. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719601 · Cited by 50
“These issues have been addressed in a recent review article [48], but the following three sets of observations summarize the evidence linking insulin resistance/hyperinsulinemia to essential hypertension.”
BackgroundSelf-citationContribution of insulin resistance to vascular dysfunction
Anfossi, G., Russo, I., Doronzo, G., & Trovati, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903136791 · Cited by 54
“…action Insulin resistance is defined as a less than expected response of target organs to the hormone (Olefsky et al., 1973) and is a common feature characterizing obesity, impaired glucose tolerance and type 2 diabetes mellitus (Olefsky et al., 1973; De Fronzo & Ferrannini, 1991; Reaven, 2003).”
BackgroundInsulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells
Eid, H. M. A., Lyberg, T., Arnesen, H., & Seljeflot, I. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.008 · Cited by 55
El‐Bassossy, H. M., Badawy, D., Neamatallah, T., & Fahmy, A. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.013 · Cited by 49
Stability of bioactives in flaxseed and flaxseed-fortified foods
Edel, A. L., Aliani, M., & Pierce, G. N. (2015) · Food Research International · doi:10.1016/j.foodres.2015.07.035 · Cited by 50
Fructose-Fed Rats Are Protected against Ischemia/Reperfusion Injury
Jordan, J. E., Simandle, S. A., Tulbert, C. D., Busija, D. W., & Miller, A. W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055970 · Cited by 47
“Without necessary diet and lifestyle changes, the insulin-resistant syndrome usually progresses to type II diabetes mellitus (Reaven, 2003).”
BackgroundDiet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis
Hawkins, J. S., Lo, J. Y., Casey, B. M., McIntire, D. D., & Leveno, K. J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.11.049 · Cited by 51
Salt-Sensitivity of Blood Pressure and Insulin Resistance
Ertuğlu, L. A., Elijovich, F., Laffer, C. L., & Kirabo, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.793924 · Cited by 47
“In fact, epidemiological studies suggest that approximately 50% of salt sensitive individuals are insulin resistant (Reaven, 2003), independent of confounding factors such as age, obesity, and glucose intolerance (Galletti et al., 1997).”
BackgroundMarsh, J. B. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.nov.363-375 · Cited by 45
Mice lacking the thyrotropin-releasing hormone gene: what do they tell us?
Yamada, M., Satoh, T., & Mori, M. (2003) · Thyroid · doi:10.1089/10507250360731505 · Cited by 42
“Because there is a large number of evidence that insulin resistance is increased in prevalence in patients with essential hypertension (90), it is of interest to note that the interaction of leptin with TRH contributes to development of hypertension in obesity (91).”
José, G. S., Bidegain, J., Robador, P. A., Díez, J., Fortuño, A., & Zalba, G. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.009 · Cited by 46
Fallo, F., Pozza, A. D., Sonino, N., Federspil, G., Ermani, M., Baroselli, S., Catena, C., Soardo, G., Carretta, R., Belgrado, D., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830dfe4b · Cited by 43
“Arterial hypertension is referred as an insulin-resistant state, even in the absence of other metabolic abnormalities and insulin resistance may disorder [8,9].”
Girman, C. J., Dekker, J. M., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi229 · Cited by 41
“The association between hypertension and metabolic syndrome has been challenged, although elevated blood pressure in combination with insulin resistance may be integral to the development of cardiovascular disease (50, 51).”
BackgroundRisk Factors Preceding Type 2 Diabetes and Cardiomyopathy
Singh, S., Dhingra, S., Ramdath, D. D., Vasdev, S., Gill, V. D., & Singal, P. K. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9197-3 · Cited by 42
“Hypertension is also associated with insulin resistance [57, 58], and approximately 50% of hypertensives have altered glucose metabolism [163, 216].”
BackgroundConsenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica
López-Jaramillo, P. A., Sanchez, R. A., Diaz, M., Cobos, L., Bryce, A., Parra-Carrillo, J. Z., Lizcano, F., Lanas, F. T., Sinay, I. R., Sierra, I. D., et al. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003019 · Cited by 90
“It is commonly accepted that all components of metabolic syndrome are associated with insulin resistance [26,62,63].”
BackgroundRole of Obesity in Complicating and Confusing the Diagnosis and Treatment of Diabetes in Children
Jones, K. L. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1234 · Cited by 42
The brain–adipose axis: A review of involvement of molecules
Shimizu, H., & Mori, M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047245 · Cited by 44
“The circulating concen- tration of insulin is higher in obese people, and this is a good indicator of insulin resistance (Reaven 2003).”
BackgroundNovel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes
Dillon, E. L., Janghorbani, M., Angel, J. A., Casperson, S. L., Grady, J. J., Urban, R. J., Volpi, E., & Sheffield‐Moore, M. (2008) · Diabetes Care · doi:10.2337/dc08-1578 · Cited by 40
Role of insulin resistance in Alzheimer’s disease
Cai, Z., Xiao, M., Chang, L., & Yan, L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9631-3 · Cited by 42
“hyperglycemia via compensatory hyperinsulinemia (Reaven 2003; Sarafidis and Bakris 2006).”
BackgroundSartori, M., Ceolotto, G., Papparella, I., Baritono, E., Ciccariello, L., Calò, L., Leoni, M., & Semplicini, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.017 · Cited by 42
Chu, J. W., Abbasi, F., Lamendola, C. A., McLaughlin, T., Reaven, G. M., & Tsao, P. S. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.004 · Cited by 38
“Introduction Insulin-resistant individuals are at increased risk for development of a cluster of abnormalities that increase risk of cardiovascular disease (CVD), including dyslipidaemia, essential hypertension, a pro-coagulant state, endothelial dysfunction and evidence of increased inflammation.(1-7)”
BackgroundSelf-citationHypertension, Obesity, and Inflammation: The Complex Designs of a Deadly Trio
Rizvi, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0116 · Cited by 41
Health-Related Quality of Life in Adolescents with or at Risk for Type 2 Diabetes Mellitus
Rhodes, E. T., Goran, M. I., Lieu, T. A., Lustig, R. H., Prosser, L. A., Songer, T. J., Weigensberg, M. J., Weinstock, R. S., Gonzalez, T. V., Rawluk, K., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.11.026 · Cited by 36
“We did not require that laboratory criteria be met for all subjects as screening practices at sites varied, biochemical definitions for IR are not well established (25), and our goal was to identify patients perceived to be at heightened clinical risk for T2DM.”
BackgroundСалухов, В. В., Khalimov, Y. S., Борисович, Ш. С., & Kadin, D. V. (2018) · Diabetes Mellitus · doi:10.14341/dm9570 · Cited by 36
Zamolodchikova, T. S., Tolpygo, S. M., & Kotov, A. V. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1293221 · Cited by 37
A practical approach to the metabolic syndrome: review of current concepts and management
Tota-Maharaj, R., Defilippis, A. P., Blumenthal, R. S., & Blaha, M. J. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32833cd474 · Cited by 36
Ünek, İ. T., Bayraktar, F., Solmaz, D., Ellıdokuz, H., Yüksel, F., Şişman, A. R., & Yeşil, S. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.034 · Cited by 36
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Eid, H. M. A., Reims, H. M., Arnesen, H., Kjeldsen, S. E., Lyberg, T., & Seljeflot, I. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.003 · Cited by 37
“Insulin is an important component of the metabolic syndrome in which the clustering of factors such as obesity, dyslipidemia, hypertension, and insulin resistance leads to a substantial increase in cardiovascular risk [1,2].”
BackgroundVladu, I. M., Forţofoiu, M., Clenciu, D., Forțofoiu, M.-C., Pădureanu, R., Radu, L., Cojan, Ș., Rădulescu, P. M., & Pădureanu, V. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10996 · Cited by 38
“The resulting dyslipidemia is extremely atherogenic and represents at least part of the increased risk of CVD in insulin‐resistant individ‐ uals (7,8).”
BackgroundPlasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension
Doğru, T., Sönmez, A., Taşçı, İ., Yılmaz, M. İ., Erdem, G., Erturk, H., Bingöl, N., Kilic, S., & Ozgurtas, T. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002114 · Cited by 36
Carmichael, J. D., Danoff, A., Milani, D., Roubenoff, R., Lesser, M. L., Livote, E., Reitz, R. E., Ferris, S., & Kleinberg, D. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02569.x · Cited by 35
Sinaiko, A. R., & Caprio, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.012 · Cited by 40
Lo, A., Lo, C. C. W., & Oliver‐Williams, C. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead061 · Cited by 34
Muresanu, D. F., & Sharma, H. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.001 · Cited by 33
Fructose-Fed Rat Hearts are Protected Against Ischemia-Reperfusion Injury
Joyeux‐Faure, M., Rossini, E., Ribuot, C., & Faure, P. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100411 · Cited by 35
The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions
Sorriento, D., Rusciano, M. R., Visco, V., Fiordelisi, A., Cerasuolo, F. A., Poggio, P., Ciccarelli, M., & Iaccarino, G. (2021) · Cells · doi:10.3390/cells10010167 · Cited by 35
“Insulin resistance is a pathological condition in which target tissues fail to respond to insulin stimulation, leading to hyperglycemia and compensative hyperinsulinemia [73].”
BackgroundTomé, M. A., Botana, M., Cadarso-Suárez, C., Iraeta, A. R., Fernández-Mariño, A., Mato, J. A. M., Solache, I., & Pérez-Fernández, R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346497 · Cited by 32
Prehypertension is associated with insulin resistance
Hwu, C., Liou, T., Hsiao, L.-C., & Lin, M. (2009) · QJM · doi:10.1093/qjmed/hcp107 · Cited by 32
SONG, D., Arikawa, E., Galipeau, D., YEH, J., Battell, M. L., Yuen, V. G., & McNeill, J. H. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.04.003 · Cited by 31
Korandji, C., Zeller, M., Guilland, J.-C., Collin, B., Lauzier, B., Sicard, P., Duvillard, L., Goirand, F., Moreau, D., Cottin, Y., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.014 · Cited by 32
“Insulin resistance (IR), as well as hypertension and hyperlycemia, is a central component of metabolic syndrome, and has een associated with an increase in cardiovascular risk [1].”
BackgroundQureshi, K., Clements, R. H., Saeed, F., & Abrams, G. A. (2010) · Journal of Obesity · doi:10.1155/2010/741521 · Cited by 32
“The presence of IR in non-diabetic individuals portends higher risk of developing NAFLD, DM or cardiovascular disease [21].”
BackgroundA closer look at the role of urotensin II in the metabolic syndrome
Barrette, P.-O., & Schwertani, A. G. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00165 · Cited by 32
“Such high plasma insulin levels promote hypertension (Welborn et al., 1966; Reaven, 2003), which is another risk factor of MetS.”
Background
Metadata
- Authors
- Reaven, G. M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Reaven, Gerald M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2399-2403
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033704972
- Semantic Scholar
- 273ddc01929a0f425076be991fd96bb78d531c52
- Cited by
- 284
- References
- 43
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 17 · 2012: 14
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, compensatory hyperinsulinemia, essential hypertension, cardiovascular disease, blood pressure regulation, insulin-stimulated glucose disposal, fasting insulin
- MeSH terms
- Adaptation, Physiological, Cardiovascular Diseases, Humans, Hyperinsulinism, Hypertension, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.